Published in Cancer Weekly, April 14th, 2009
The Breitling family of patents covers the use of full-length pIII phage protein as a scaffold in a phagemid vector, and is one of the fundamental groups of patents for the phagemid display of antibody, antibody...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.